The life sciences industry of Indiana?

[Anonymous]

Huh? You must be talking about Dow Agrosciences, because it's just not anything remotely related to Lilly. Lilly is more of a financial engineering firm. You have various inputs, and out comes a tidy 6% dividend that always seems to increase despite lack of new products, consistently being outsmarted by the competition on existing products, record lawsuits for fraudulent marketing, ad nauseum.

 

[Anonymous]

Huh? You must be talking about Dow Agrosciences, because it's just not anything remotely related to Lilly. Lilly is more of a financial engineering firm. You have various inputs, and out comes a tidy 6% dividend that always seems to increase despite lack of new products, consistently being outsmarted by the competition on existing products, record lawsuits for fraudulent marketing, ad nauseum.

It is an Enron-esque, Ponzi operation which exists only to enrich the redundant layers of so-called 'management' which has spawned from the lowest guttervermin effluent of the White River. The collapse is underway; stand back and enjoy from a distance.

 

[Anonymous]

Dont forget the 20 billion dollars a year we make kinda, comes in handy

 

[Anonymous]

Dont forget the 20 billion dollars a year we make kinda, comes in handy

Handy for what?

World class investment in US research facilities?

Sure, it's handy.

I'll pass along your comment to the 50% unemployed among science graduates in the US.

 

[Anonymous]

Huh? You must be talking about Dow Agrosciences, because it's just not anything remotely related to Lilly. Lilly is more of a financial engineering firm. You have various inputs, and out comes a tidy 6% dividend that always seems to increase despite lack of new products, consistently being outsmarted by the competition on existing products, record lawsuits for fraudulent marketing, ad nauseum.

tawdry 6% ?

 

[Anonymous]

Huh? You must be talking about Dow Agrosciences, because it's just not anything remotely related to Lilly. Lilly is more of a financial engineering firm. You have various inputs, and out comes a tidy 6% dividend that always seems to increase despite lack of new products, consistently being outsmarted by the competition on existing products, record lawsuits for fraudulent marketing, ad nauseum.

at $4.30, Lilly can boast of 100% dividend..yippy

 

[Anonymous]

Dont forget the 20 billion dollars a year we make kinda, comes in handy

Enron was approaching valuation of 1 trilion dollar before someone -- a woman -- spilled the guts of the company. Enron was making $24 billion in profit...so Lilly's 20 billion sounds reasonable to me.

 

[Anonymous]

Enron was approaching valuation of 1 trilion dollar before someone -- a woman -- spilled the guts of the company. Enron was making $24 billion in profit...so Lilly's 20 billion sounds reasonable to me.

Maybe that explains Lilly USA, LLY OUS, etc.... maybe just ways of pushing money around to appear profitable. We'll see over the next two years.

Tune in daily for more amusement.

 

[Anonymous]

Maybe that explains Lilly USA, LLY OUS, etc.... maybe just ways of pushing money around to appear profitable. We'll see over the next two years.

Tune in daily for more amusement.

Don't forget how $1billion/year can be added to the bottom line by CUTTING JOBS.

Okay, if 5500=$1b cash flow, why not lay off everyone at Lilly? Just a crack A-team at the corporate center, everything FIPNETTED out...

 

[Anonymous]

Don't forget how $1billion/year can be added to the bottom line by CUTTING JOBS.

Okay, if 5500=$1b cash flow, why not lay off everyone at Lilly? Just a crack A-team at the corporate center, everything FIPNETTED out...

Dont give away the plan!

 

[Anonymous]

Dont give away the plan!

Similar plans at other multibillion dollar pharmaceutical firms have produced abundant cash flow. Sure there are no new products of any value buy hey, it's the quarterly RESULTS THAT MATTER.